Literature DB >> 7072745

Active tuberculosis undiagnosed until autopsy.

I D Bobrowitz.   

Abstract

In this report 21 patients in whom tuberculosis was the primary cause of death, but which was not diagnosed until necropsy, are reviewed. Of the 21 deaths, 11 were due to pulmonary tuberculosis and 10 to miliary tuberculosis. Proper evaluation of the following factors might have led to the correct diagnosis in many of the patients: A family history of tuberculosis, prior pleurisy, a gastrectomy, diabetes mellitus or end-stage renal failure; all can be associated with an increased incidence of tuberculosis. A negative tuberculin skin reaction does not exclude the presence of active tuberculosis. In the search for Mycobacterium tuberculosis, the examination of just one or two sputum specimens is not an adequate bacteriologic investigation. A positive gastric smear can have diagnostic importance. Ascitic fluid findings can be characteristic of tuberculous peritonitis. A negative bone marrow aspirate for acid-fast bacilli does not exclude miliary tuberculosis. Significant anemia, high fever and leukopenia increases the possibility of tuberculosis. The persistence and/or progression of lung infiltration, irrespective of supposedly specific antibiotic therapy, strongly suggests tuberculosis. Miliary tuberculosis can present as an adult respiratory distress syndrome. All but one patient in this series had fever. the failure to diminish the pyrexia believed due to specific lung infections with presumably effective antibiotics, and the inability of therapy to control other conditions thought to cause the fever indicate the presence of tuberculosis. Tuberculosis, especially miliary disease, should be considered as a possible etiology of fever of unknown origin. If the diagnosis of tuberculosis is highly suggestive, even without bacteriologic confirmation, a therapeutic trial of antituberculosis drugs should be given.

Entities:  

Mesh:

Year:  1982        PMID: 7072745     DOI: 10.1016/0002-9343(82)90476-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

1.  Overestimation of clinical diagnostic performance caused by low necropsy rates.

Authors:  K G Shojania; E C Burton; K M McDonald; L Goldman
Journal:  Qual Saf Health Care       Date:  2005-12

2.  Tuberculous pyomyositis of forearm muscles.

Authors:  Sagar Narang
Journal:  Hand (N Y)       Date:  2008-08-20

3.  Mycobacterium tuberculosis at autopsy--exposure and protection: an old adversary revisited.

Authors:  R J Flavin; N Gibbons; D S O'Briain
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

Review 4.  Assessing the autopsy.

Authors:  P N Nemetz; J Ludwig; L T Kurland
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

Review 5.  Problems in diagnosing infections in the elderly.

Authors:  D J Flournoy; M A Bernard
Journal:  J Natl Med Assoc       Date:  1993-11       Impact factor: 1.798

6.  Challenges in assessing transmission of Mycobacterium tuberculosis in long-term-care facilities.

Authors:  David A Jackson; Karen Mailer; Kimberly A Porter; R Todd Niemeier; Donna A Fearey; Linda Pope; Lauren A Lambert; Kiren Mitruka; Marie A de Perio
Journal:  Am J Infect Control       Date:  2015-05-05       Impact factor: 2.918

7.  [24-year survival in chronic myeloid leukemia].

Authors:  L Müller; R Hehlmann
Journal:  Klin Wochenschr       Date:  1987-07-15

Review 8.  An atlas overview of characteristic features of tuberculosis that may be encountered at autopsy.

Authors:  Lilli Stephenson; Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2019-08-30       Impact factor: 2.007

Review 9.  Imaging of pulmonary tuberculosis.

Authors:  P Van Dyck; F M Vanhoenacker; P Van den Brande; A M De Schepper
Journal:  Eur Radiol       Date:  2002-08-10       Impact factor: 5.315

10.  Miliary tuberculosis and adult respiratory distress syndrome.

Authors:  A R Piqueras; L Marruecos; A Artigas; C Rodriguez
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.